Business Context and Reporting Period
This Form 8-K filing by Dragonfly Energy Holdings Corp. (DFLI) covers the date of December 31, 2024. The report details a material definitive agreement entered into on that date regarding the company's Term Loan, Guarantee and Security Agreement.
Key Financial Metrics and Liquidity
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. However, it discloses specific liquidity and debt covenant adjustments:
- Liquidity Requirement: Reduced to $3.5 million as of the last day of the fiscal month ended December 31, 2024.
- Debt Covenant Compliance: The company obtained a waiver for non-compliance with the Senior Leverage Ratio and Fixed Charge Coverage Ratio tests for the quarter ended December 31, 2024.
- Interest Payment Structure: Interest due on January 1, 2025, will be paid partly in cash and partly in-kind (PIK).
Material Changes and Agreements
On December 31, 2024, the Company, Dragonfly Energy Corp., and Battle Born Battery Products, LLC entered into a Limited Waiver and Fourth Amendment to their Loan Agreement with lenders. Key changes include:
- Issuance of Penny Warrants: A one-time issuance of warrants to purchase up to 350,000 shares of common stock at an exercise price of $0.01 per share was granted to lenders in exchange for the covenant waiver.
- Accrued Warrants: The company agreed to issue additional penny warrants based on a formula upon the earlier of five business days after the end of the "Waiver Period" or five business days prior to a Change of Control.
- Shareholder Approval Requirement: The company must use commercially reasonable efforts to obtain shareholder approval for the issuance of up to 1,400,000 shares underlying these warrants in accordance with Nasdaq Rules 5635(b) and 5635(d).
- Support Agreement: A support agreement was executed with shareholders holding over 20% of voting stock to vote in favor of the warrant issuance proposal.
- Waiver Period: Lenders' rights to receive additional warrant shares in connection with the Committed Equity Facility are suspended from December 31, 2024, until the earliest of shareholder approval, a Change of Control, or December 31, 2025.
Guidance, Risks, and Unusual Items
The filing does not contain forward-looking guidance or management commentary on future operational performance. The primary risks and contingencies identified are:
- Dilution Risk: The issuance of penny warrants and potential accrued warrants will result in significant dilution to existing shareholders upon exercise.
- Regulatory Compliance: The validity of the warrant issuance is contingent upon obtaining shareholder approval under Nasdaq listing rules.
- Covenant Compliance: The company currently does not meet its Senior Leverage Ratio and Fixed Charge Coverage Ratio tests, necessitating the waiver.
- Unregistered Securities: The penny warrants are being offered pursuant to Section 4(a)(2) of the Securities Act and are not registered.
Investor Verification Checklist
- Verify the status of the shareholder vote required to approve the issuance of up to 1,400,000 warrant shares.
- Confirm the exact calculation of "Accrued Warrant Shares" and the potential total dilution impact.
- Review the full text of the Fourth Amendment (Exhibit 10.1) to understand the specific terms of the PIK interest and the definition of the "Waiver Period."
- Monitor the company's ability to maintain the reduced liquidity requirement of $3.5 million.
- Check for any subsequent filings regarding the outcome of the shareholder approval process.